February 11, 2025
Aptevo Therapeutics Inc. Announces Closing of Previously Announced $5 Million Public Offering

SEATTLE, WA / ACCESSWIRE / August 4, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO) (“Aptevo” or the “Company”), a clinical stage biotechnology company focused on developing novel immuno-oncology therapeutics, today announced the closing of its previously announced public offering of 2,221,550 shares of common stock at a purchase price of $0.62 per share…
Read More

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *